These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6978665)

  • 1. Effects of drugs and antibodies on the post-synaptic membrane of the neuromuscular junction.
    Peper K; Sterz R; Bradley RJ
    Ann N Y Acad Sci; 1981; 377():519-43. PubMed ID: 6978665
    [No Abstract]   [Full Text] [Related]  

  • 2. The neuromuscular junction: recent developments.
    Bowman WC
    Eur J Anaesthesiol; 1985 Mar; 2(1):59-93. PubMed ID: 2410263
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental myasthenia: lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates.
    Hohlfeld R; Sterz R; Kalies I; Wekerle H; Peper K
    Muscle Nerve; 1983 Feb; 6(2):160-3. PubMed ID: 6304508
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro blockade of neuromuscular transmission by monoclonal anti-acetylcholine receptor antibodies.
    Maselli RA; Jow B; Richman DP; Nelson DJ
    Ann N Y Acad Sci; 1988; 540():523-4. PubMed ID: 2849901
    [No Abstract]   [Full Text] [Related]  

  • 5. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
    Molenaar PC; Oen BS; Plomp JJ; Van Kempen GT; Jennekens FG; Hesselmans LF
    Eur J Pharmacol; 1991 Apr; 196(1):93-101. PubMed ID: 1874282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of dose-response curves by quantitative ionophoresis at the frog neuromuscular junction.
    Dreyer F; Peper K; Sterz R
    J Physiol; 1978 Aug; 281():395-419. PubMed ID: 309003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion of acetylcholine in the synaptic cleft of normal and myasthenia gravis human endplates.
    Cull-Candy SG; Miledi R; Uchitel OD
    Nature; 1980 Jul; 286(5772):500-2. PubMed ID: 7402330
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of myasthenic immunoglobulins and of prednisolone on spontaneous miniature end-plate potentials in mouse diaphragms.
    Dudel J; Birnberger KL; Toyka KV; Schlegel C; Besinger U
    Exp Neurol; 1979 Nov; 66(2):365-80. PubMed ID: 226390
    [No Abstract]   [Full Text] [Related]  

  • 9. Properties of end-plate channels in rats immunized against acetylcholine receptors.
    Alemà S; Cull-Candy SG; Miledi R; Trautmann A
    J Physiol; 1981 Feb; 311():251-66. PubMed ID: 6267252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis.
    Ito Y; Miledi R; Vincent A; Newsom-Davis J
    Brain; 1978 Jun; 101(2):345-68. PubMed ID: 667602
    [No Abstract]   [Full Text] [Related]  

  • 11. The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis.
    Engel AG
    Prog Brain Res; 1979; 49():423-34. PubMed ID: 515440
    [No Abstract]   [Full Text] [Related]  

  • 12. Endplate blocking actions of lophotoxin.
    Atchison WD; Narahashi T; Vogel SM
    Br J Pharmacol; 1984 Jul; 82(3):667-72. PubMed ID: 6146369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do peripheral nerves contain a factor inducing acetylcholine sensitivity in skeletal muscle?
    Vyskocil F; Syrový I
    Experientia; 1979 Feb; 35(2):218-9. PubMed ID: 421836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors.
    Lennon VA; Lambert EH
    Nature; 1980 May; 285(5762):238-40. PubMed ID: 6154894
    [No Abstract]   [Full Text] [Related]  

  • 15. Voltage dependence of agonist effectiveness at the frog neuromuscular junction: resolution of a paradox.
    Dionne VE; Stevens CF
    J Physiol; 1975 Oct; 251(2):245-70. PubMed ID: 1081139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How myasthenia gravis alters the safety factor for neuromuscular transmission.
    Ruff RL; Lennon VA
    J Neuroimmunol; 2008 Sep; 201-202():13-20. PubMed ID: 18632162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-receptor interaction at the frog neuromuscular junction.
    Dreyer F; Peper K; Sterz R; Bradley RJ; Müller KD
    Prog Brain Res; 1979; 49():213-23. PubMed ID: 42113
    [No Abstract]   [Full Text] [Related]  

  • 18. Duchenne dystrophy: ultrastructural localization of the acetylcholine receptor and intracellular microelectrode studies of neuromuscular transmission.
    Sakakibara H; Engel AG; Lambert EH
    Neurology; 1977 Aug; 27(8):741-5. PubMed ID: 196235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of forskolin on the response of acetylcholine receptors in frog sartorius endplate.
    Deana A; Scuka M
    Neurosci Lett; 1990 Jul; 114(3):272-6. PubMed ID: 1698269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization at the frog neuromuscular junction: a biphasic process.
    Feltz A; Trautmann A
    J Physiol; 1982 Jan; 322():257-72. PubMed ID: 6978400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.